Massachusetts Financial Services CO Atea Pharmaceuticals, Inc. Transaction History

Massachusetts Financial Services CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$5.49 - $8.79 $2,552 - $4,087	-465 Reduced 0.9%	51,137 $291,000
Q2 2022 Aug 09, 2022	BUY	$5.33 - $8.18 $1,380 - $2,118	259 Added 0.5%	51,602 $366,000
Q1 2022 May 11, 2022	BUY	$5.5 - $9.19 $2,898 - $4,843	527 Added 1.04%	51,343 $371,000
Q4 2021 Feb 10, 2022	BUY	$7.67 - $44.59 $389,758 - $2.27 Million	50,816 New	50,816 $454,000

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $270M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.